Specific Deletion of Interleukin‐1 Beta in Microglia Improves Acute Outcome and Modulates Neurogenesis After Ischemic Stroke
Authors:
- Alba GraystonAGAlba Grayston
- Margarida BaptistaMBMargarida Baptista
- Kelly WemyssKWKelly Wemyss
- Ruby TaylorRTRuby Taylor
- Grace CullenGCGrace Cullen
- Nadim LukaNLNadim Luka
- Joshua R. CoxJCJoshua R. Cox
- Joanne E. KonkelJKJoanne E. Konkel
- David BroughDBDavid Brough
- Stuart M. AllanSAStuart M. Allan
- Emmanuel PinteauxEPEmmanuel Pinteaux
Open Access
Abstract
Interleukin‐1 (IL‐1) signaling is a major driver of post‐ischemic neuroinflammation, yet the cell‐ and isoform‐specific roles of the two major IL‐1 receptor type 1 agonists, IL‐1α and IL‐1β, remain incompletely defined in the context of stroke. Microglia rapidly express IL‐1α after cerebral ischemia, whereas IL‐1β expression is delayed and restricted to a small subset of microglia and infiltrating immune cells. Here, we investigated for the first time the specific contribution of microglial‐derived IL‐1β to acute injury and post‐stroke neurorepair after transient middle cerebral artery occlusion in male and female mice, through microglial‐specific tamoxifen‐inducible Cre‐loxP‐mediated recombination. Deletion of microglial IL‐1β improved acute neurological outcomes, reduced neutrophil accumulation in the ischemic brain, and dampened systemic inflammatory cytokines. These effects were most evident during the acute phase and in females in mice. In contrast, long‐term functional recovery was largely unaffected. However, microglial IL‐1β deletion differentially regulated post‐stroke neurogenesis, enhancing subventricular zone neurogenic responses and ectopic neuroblast migration while limiting hippocampal neurogenesis. Together, these findings identify microglial IL‐1β as a key amplifier of early inflammatory injury after stroke, exerting region‐specific effects on neurogenic niches, and highlight distinct, non‐redundant roles for microglial IL‐1 isoforms in ischemic brain injury and repair.Keywords
Funding Information
- British Heart Foundation (PG/21/10730)
- Medical Research Council (MR/T016515/1)
This publication has 28 references indexed in Scilit:
- A comparative analysis of microglial inducible Cre linesCell Reports, 2023
- Role of signal transduction pathways in IL‐1β‐induced apoptosis: Pathological and therapeutic aspectsImmunity, Inflammation and Disease, 2023
- Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrierBrain, Behavior, & Immunity - Health, 2021
- Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune ActivitiesImmunity, 2019
- Interleukin-1 mediates ischaemic brain injury via distinct actions on endothelial cells and cholinergic neuronsBrain, Behavior, and Immunity, 2019
- Applicability of the grip strength and automated von Frey tactile sensitivity tests in the mouse photothrombotic model of strokeBehavioural Brain Research, 2018
- Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemiaBrain, Behavior, and Immunity, 2017
- Negative regulation of TLX by IL-1β correlates with an inhibition of adult hippocampal neural precursor cell proliferationBrain, Behavior, and Immunity, 2013
- Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under HomeostasisImmunity, 2013
- Interleukin-1 receptor antagonist reverses stroke-associated peripheral immune suppressionCytokine, 2012